Concepedia

Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway

Ying Zhang, Qianyin Huang, Yihua Chen, Peng Xuan, Yuxian Wang, Shuting Li, Jiayu Wu, Congwei Luo, Wangqiu Gong, Bohui Yin,

International Immunopharmacology · 2019 · 50 citations · 24 references

DOI

Concepts

References

24

Characterization of SIS3, a Novel Specific Inhibitor of Smad3, and Its Effect on Transforming Growth Factor-β1-Induced Extracellular Matrix Expression

Masatoshi Jinnin, Hironobu Ihn, Kunihiko Tamaki · Molecular Pharmacology · 2005 · 449 citations

, , +13

The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex.

Steffen P. Hehner, Thomas G. Hofmann, Wulf Dröge et al. · PubMed · 1999 · 386 citations

, , +17

Pathogenesis of Peritoneal Fibrosing Syndromes (Sclerosing Peritonitis) in Peritoneal Dialysis

James W. Dobbie · Peritoneal Dialysis International · 1992 · 378 citations

, , +15

The Antiinflammatory Sesquiterpene Lactone Parthenolide Inhibits NF-κB by Targeting the IκB Kinase Complex

Steffen P. Hehner, Thomas G. Hofmann, Wulf Dröge et al. · The Journal of Immunology · 1999 · 355 citations · Full text

, , +17

Five subtypes of type A gamma-aminobutyric acid receptors identified in neurons by double and triple immunofluorescence staining with subunit-specific antibodies.

Jean‐Marc Fritschy, Dietmar Benke, S. Mertens et al. · Proceedings of the National Academy of Sciences · 1992 · 345 citations

, , +13